XML 61 R44.htm IDEA: XBRL DOCUMENT v3.22.2.2
STOCK-BASED COMPENSATION AND INCENTIVE PERFORMANCE PLANS (Tables)
12 Months Ended
Jun. 30, 2022
Share-Based Payment Arrangement [Abstract]  
Non-Vested Restricted Stock and Restricted Share Unit Awards
A summary of the restricted stock activity (including all RSAs, RSUs and PSUs) for the last three fiscal years ended June 30 is as follows:
2022Weighted
Average 
Grant
Date Fair 
Value
(per share)
2021Weighted
Average 
Grant
Date Fair 
Value
(per share)
2020Weighted
Average 
Grant
Date Fair 
Value
(per share)
Non-vested - RSAs, RSUs and PSUs
1,780 $16.552,050 $15.852,729 $12.94
Granted873 $43.55237 $36.13990 $17.36
Vested(1,583)$15.61(375)$25.21(290)$23.28
Forfeited(280)$32.98(132)$17.18(1,379)$8.80
Non-vested - RSAs, RSUs and PSUs
790 $42.441,780 $16.552,050 $15.85
Restricted Stock Grant Information
The fair value of RSAs, RSUs and PSUs granted and of shares vested, and the tax benefit recognized from restricted shares vesting, for the last three fiscal years ended June 30 was as follows:
Fiscal Year Ended June 30,
202220212020
Fair value of restricted stock granted$38,005 $8,551 $17,179 
Fair value of restricted stock vested$71,376 $15,847 $6,775 
Tax benefit recognized from restricted stock vesting$3,658 $1,597 $939 
Schedule of Average Assumptions Grant date fair values are calculated using a Monte Carlo simulation model with weighted average grant date fair values per target share and related valuation assumptions as follows:
Absolute TSR PSUsRelative TSR PSUs
Grant date fair value (per target share)$39.00$60.09
Risk-free interest rate0.89 %0.89 %
Expected dividend yield
Expected volatility36.93 %24.46 %
Expected term2.99 years2.99 years
The weighted average grant date fair values per target share and related valuation assumptions were as follows:
Fiscal Year ended June 30,
20212020
Grant date fair value (per target share)$32.13$10.92
Risk-free interest rate0.13%1.54%
Expected dividend yield
Expected volatility40.37%36.28%
Expected term1.17 years1.85 years
The grant date fair value per target share and related valuation assumptions used in the Monte Carlo simulation to value this award were as follows:
Grant date fair value (per target share)$21.63
Risk-free interest rate2.99 %
Expected dividend yield
Expected volatility35.17 %
Expected term3.00 years
Share-based Payment Arrangement, Cost by Plan
Compensation cost and related income tax benefits recognized on the Consolidated Statements of Operations for stock-based compensation plans were as follows:
  
Fiscal Year Ended June 30,
 202220212020
Selling, general and administrative expense
$15,611 $15,659 $13,078 
Discontinued operations— — 544 
Total compensation cost recognized for stock-based compensation plans$15,611 $15,659 $13,622 
Related income tax benefit$1,574 $1,296 $1,518